Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China
· Delayed Price · Currency is CNY 10.74
+0.23 (2.19%)
Mar 10, 2026, 3:04 PM CST
SHE:301060 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 744.95 | 828.95 | 861.2 | 665.81 | 351.96 | 412.08 | Upgrade
|
| Trading Asset Securities | - | - | - | - | 420.93 | 120.63 | Upgrade
|
| Cash & Short-Term Investments | 744.95 | 828.95 | 861.2 | 665.81 | 772.89 | 532.71 | Upgrade
|
| Cash Growth | 8.78% | -3.74% | 29.35% | -13.85% | 45.09% | 9.77% | Upgrade
|
| Accounts Receivable | 730.16 | 808.63 | 1,033 | 2,249 | 819.61 | 540.05 | Upgrade
|
| Other Receivables | 8.04 | 14.54 | 6.08 | 11.83 | 7.89 | 8.18 | Upgrade
|
| Receivables | 738.2 | 823.17 | 1,040 | 2,261 | 827.5 | 548.23 | Upgrade
|
| Inventory | 319.96 | 306.09 | 367.71 | 401.52 | 139.44 | 147.13 | Upgrade
|
| Prepaid Expenses | - | - | 0.11 | 8.45 | - | - | Upgrade
|
| Other Current Assets | 40.58 | 40.43 | 57.97 | 51.56 | 27.23 | 24.84 | Upgrade
|
| Total Current Assets | 1,844 | 1,999 | 2,327 | 3,389 | 1,767 | 1,253 | Upgrade
|
| Property, Plant & Equipment | 460.03 | 482.58 | 509.74 | 220.96 | 241.11 | 117.37 | Upgrade
|
| Long-Term Investments | 1.47 | 1.76 | 14.06 | 16.74 | - | - | Upgrade
|
| Goodwill | 7.66 | 7.66 | 15.24 | 17.64 | 30.09 | 30.09 | Upgrade
|
| Other Intangible Assets | 21.17 | 24.45 | 26.5 | 13.06 | 14.81 | 12.89 | Upgrade
|
| Long-Term Accounts Receivable | - | 0.25 | - | - | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | 73.23 | 73.82 | 48.95 | 30.13 | 13.39 | 14.07 | Upgrade
|
| Long-Term Deferred Charges | 21.17 | 30.04 | 37.17 | 49.6 | 32.05 | 39.56 | Upgrade
|
| Other Long-Term Assets | 2.33 | 4.12 | 8.67 | 10.16 | 6.97 | 4.63 | Upgrade
|
| Total Assets | 2,431 | 2,623 | 2,987 | 3,747 | 2,105 | 1,472 | Upgrade
|
| Accounts Payable | 446.97 | 388.99 | 502.36 | 858.69 | 253.03 | 125.34 | Upgrade
|
| Accrued Expenses | 24.04 | 61.98 | 50.07 | 253.64 | 90.24 | 51.97 | Upgrade
|
| Short-Term Debt | 50.03 | 95.11 | 214.59 | 182.16 | 2 | - | Upgrade
|
| Current Portion of Long-Term Debt | 27.21 | 15.14 | 15.15 | - | - | - | Upgrade
|
| Current Portion of Leases | - | 12.08 | 10.77 | 16.81 | 13.67 | - | Upgrade
|
| Current Income Taxes Payable | 11.52 | 12.54 | 9.73 | 51.76 | 28.91 | 10.74 | Upgrade
|
| Current Unearned Revenue | 10.91 | 15.12 | 6.6 | 28.73 | 9.28 | 18.46 | Upgrade
|
| Other Current Liabilities | 28.19 | 14.64 | 13.55 | 22.03 | 15.85 | 11.49 | Upgrade
|
| Total Current Liabilities | 598.87 | 615.59 | 822.83 | 1,414 | 412.98 | 218.01 | Upgrade
|
| Long-Term Debt | 117.5 | 133.7 | 145.77 | - | - | - | Upgrade
|
| Long-Term Leases | 10.11 | 18.27 | 21.07 | 45.62 | 50.03 | - | Upgrade
|
| Long-Term Unearned Revenue | 7.6 | 10.42 | 11.94 | 14.68 | 2.66 | 6.12 | Upgrade
|
| Other Long-Term Liabilities | 26.34 | 25.02 | 5.09 | - | - | - | Upgrade
|
| Total Liabilities | 760.43 | 803 | 1,007 | 1,474 | 465.67 | 224.13 | Upgrade
|
| Common Stock | 400.52 | 400.52 | 400.52 | 400.52 | 400.52 | 352.46 | Upgrade
|
| Additional Paid-In Capital | 553.96 | 553.96 | 553.96 | 553.96 | 552.8 | 461.84 | Upgrade
|
| Retained Earnings | 646.94 | 727.31 | 836.75 | 1,109 | 611.62 | 407.97 | Upgrade
|
| Treasury Stock | -23.01 | -23.01 | -10.26 | - | - | - | Upgrade
|
| Comprehensive Income & Other | -0.65 | -0.65 | -0.65 | - | - | - | Upgrade
|
| Total Common Equity | 1,578 | 1,658 | 1,780 | 2,063 | 1,565 | 1,222 | Upgrade
|
| Minority Interest | 92.57 | 162.21 | 199.85 | 209.49 | 74.88 | 25.12 | Upgrade
|
| Shareholders' Equity | 1,670 | 1,820 | 1,980 | 2,273 | 1,640 | 1,247 | Upgrade
|
| Total Liabilities & Equity | 2,431 | 2,623 | 2,987 | 3,747 | 2,105 | 1,472 | Upgrade
|
| Total Debt | 204.85 | 274.29 | 407.35 | 244.59 | 65.7 | - | Upgrade
|
| Net Cash (Debt) | 540.11 | 554.66 | 453.85 | 421.22 | 707.19 | 532.71 | Upgrade
|
| Net Cash Growth | 46.01% | 22.21% | 7.75% | -40.44% | 32.75% | 9.77% | Upgrade
|
| Net Cash Per Share | 1.34 | 1.37 | 1.12 | 1.05 | 2.01 | 1.51 | Upgrade
|
| Filing Date Shares Outstanding | 398.52 | 398.52 | 399.77 | 400.52 | 400.52 | 352.46 | Upgrade
|
| Total Common Shares Outstanding | 398.52 | 398.52 | 399.77 | 400.52 | 400.52 | 352.46 | Upgrade
|
| Working Capital | 1,245 | 1,383 | 1,504 | 1,975 | 1,354 | 1,035 | Upgrade
|
| Book Value Per Share | 3.96 | 4.16 | 4.45 | 5.15 | 3.91 | 3.47 | Upgrade
|
| Tangible Book Value | 1,549 | 1,626 | 1,739 | 2,033 | 1,520 | 1,179 | Upgrade
|
| Tangible Book Value Per Share | 3.89 | 4.08 | 4.35 | 5.07 | 3.80 | 3.35 | Upgrade
|
| Buildings | - | 337.04 | 333.02 | 58.77 | 28.94 | 28.94 | Upgrade
|
| Machinery | - | 332.87 | 342 | 296.39 | 290.65 | 232.89 | Upgrade
|
| Construction In Progress | - | 0.99 | 9.52 | - | 16.98 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.